shuttlepharma.com (SHPH): Accounting Value of Company
Shuttle Pharmaceuticals develops drugs to enhance the impact of radiation on solid tumors while reducing the radiation load on the body. This price chart visualizes the asset's dynamics, with a value currently at 0.09. The business relies on partnerships with scientific centers to develop sensitizers, and current operations are funded through the gradual drawdown of existing cash reserves for R&D.
Financial and market metric breakdowns for Shuttle Pharmaceuticals Holdings (SHPH)
This indicator reflects the dynamics of the company's net assets minus all liabilities, neutralizing market noise and distortions caused by rate volatility. By analyzing the trajectory of the balance sheet capitalization of Shuttle Pharmaceuticals (SHPH), an investor assesses the real value of the business, which is critical for Shuttle Pharmaceuticals (SHPH) when capitalizing on the sales potential of radiotherapy enhancement drugs in oncology clinics.